Consistent with the immunohistochemical data, in the pancreatic adenocarcinoma cell line with elevated expression of TRPM7, targeted silencing of TRPM7 impairs the cancer cells ability of invasion. This evidence concerns the gene TRPM7 and pancreatic adenocarcinoma.